Global Biotechnology Market – North America is expected to account for higher market share of more than 45% driven by increasing investment in U.S. on healthcare than other countries and has a high growth rate amongst other countries – Market Analysis and Forecast 2019 – 2026

Global Biotechnology Market – North America is expected to account for higher market share of more than 45% driven by increasing investment in U.S. on healthcare than other countries and has a high growth rate amongst other countries – Market Analysis and Forecast 2019 – 2026

Market Scenario

Global Biotechnology Market is expected to grow at a CAGR of 14% to reach US$ XX  million in 2026. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. The growth is coupled with rising demand of modern and innovative technologies such as DNA sequencing, recombinant technology, fermentation, tissue engineering. Further, rising demand for food to meet the need of ever increasing population and scarce availability of non-renewable natural resources also expected to drive the biotechnology market. Application of Genetic engineering and Genetic Modification (GM) processes to agricultural food products also expected to drive the business growth. Furthermore, decreasing prices of DNA sequencing technologies will encourage R&D activities to better understand genetic variations and develop therapeutic solutions. Moreover, development of novel techniques and their implementation by the organisation by collaborating with the other participants will drive the Global Biotechnology Market. Further, increasing demand for therapeutic and diagnostic solutions on principles of red biotechnology, DNA sequencing, and recombinant technology is expected to drive the Global Biotechnology Market through 2024. Increasing prevalence of diseases such as hepatitis B, cancer, and other orphan disorders is also expected to fuel demand in the forecast period. In 2017, North America dominated the overall market. The market growth is driven by the increasing R&D investments relating to new drug discovery and development. U.S. held highest market in North America due to increasing level of per capita spending on healthcare than other countries and has a high growth rate amongst other countries. According to the estimates published by OECD Health Statistics in 2014, it has been estimated that in 2012, U.S. spent nearly 16.9% of its GDP towards healthcare expenditure, which is the highest. The fact supports the estimated share of Global Biotechnology Market. Asia Pacific is expected to have higher growth rate in the forecast period owing to the presence of patient awareness, rapidly improving healthcare infrastructure, and rising healthcare expenditure levels in the emerging markets. Global Biotechnology Market include the developing economies of China and India. In 2017, nanobiotechnology held the highest market share. The Global Biotechnology Market growth is driven by fermentation and cell-based assay segments owing to rising R&D initiatives by various biotechnological and pharmaceutical companies. The objective of the report is to present comprehensive Global Biotechnology Market    including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Biotechnology Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Biotechnology Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Biotechnology Market  North America for Asia Pacific make the report investor’s guide. Market Segmentation •Global Biotechnology Market, By Technology o DNA Sequencing o Nanobiotechnology o Tissue engineering and Regeneration o Fermentation o Cell Based Assay o PCR Technology o Chromatography Market o Others • Global Biotechnology Market, By Applications o Health o Food & Agriculture o Natural Resources & Environment o Industrial Processing o Bioinformatics o Others The above data will be provided for following regions/countries from 2013-2024 (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia What information is covered in report? • Actual market numbers from 2018-2026, estimates and forecasts from 2018 to 2026 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2017

Table of Contents

Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Biotechnology Market overview 2.1.1. By Technology 2.1.2. By Applications Chapter 3 Global Biotechnology Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Rising demand for DNA sequencing 3.2.1.2. Increasing prevalence of various diseases 3.2.2. Market Restrains 3.2.2.1. Risks associated with GM organisms and crops 3.2.2.2. Ethical issues associated with clinical trials 3.3. Market share analysis 3.3.1. By Technology 3.3.2. By Applications 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Biotechnology Market, By Technology 4.1. Key segment trends 4.2. DNA Sequencing 4.2.1. Market size, by region, 2019-2026 4.3. Nanobiotechnology 4.3.1. Market size, by region, 2019-2026 4.4. Tissue engineering and Regeneration 4.4.1. Market size, by region, 2019-2026 4.5. Fermentation 4.5.1. Market size, by region, 2019-2026 4.6. Cell Based Assay 4.6.1. Market size, by region, 2019-2026 4.7. PCR Technology 4.7.1. Market size, by region, 2019-2026 4.8. Chromatography Market 4.8.1. Market size, by region, 2019-2026 4.9. Others 4.9.1. Market size, by region, 2019-2026 Chapter 5 Biotechnology Market, By Applications 5.1. Key segment trends 5.2. Health 5.2.1. Market size, by region, 2019-2026 5.3. Food & Agriculture 5.3.1. Market size, by region, 2019-2026 5.4. Natural Resources & Environment 5.4.1. Market size, by region, 2019-2026 5.5. Industrial Processing 5.5.1. Market size, by region, 2019-2026 5.6. Bioinformatics 5.6.1. Market size, by region, 2019-2026 5.7. Others 5.7.1. Market size, by region, 2019-2026 Chapter 6 Biotechnology Market, By Region 6.1. Key regional trends 6.2. North America 6.2.1. Market size, by country, 2019-2026 6.2.2. Market size, by technology, 2019-2026 6.2.3. Market size, by applications, 2019-2026 6.2.4. U.S. 6.2.4.1. Market size, by technology, 2019-2026 6.2.4.2. Market size, by applications, 2019-2026 6.2.5. Canada 6.2.5.1. Market size, by technology, 2019-2026 6.2.5.2. Market size, by applications, 2019-2026 6.3. Europe 6.3.1. Market size, by country, 2019-2026 6.3.2. Market size, by technology, 2019-2026 6.3.3. Market size, by applications, 2019-2026 6.3.4. Germany 6.3.4.1. Market size, by technology, 2019-2026 6.3.4.2. Market size, by applications, 2019-2026 6.3.5. UK 6.3.5.1. Market size, by technology, 2019-2026 6.3.5.2. Market size, by applications, 2019-2026 6.3.6. France 6.3.6.1. Market size, by technology, 2019-2026 6.3.6.2. Market size, by applications, 2019-2026 6.3.7. Spain 6.3.7.1. Market size, by technology, 2019-2026 6.3.7.2. Market size, by applications, 2019-2026 6.3.8. Italy 6.3.8.1. Market size, by technology, 2019-2026 6.3.8.2. Market size, by applications, 2019-2026 6.4. Asia Pacific 6.4.1. Market size, by country, 2019-2026 6.4.2. Market size, by technology, 2019-2026 6.4.3. Market size, by applications, 2019-2026 6.4.4. India 6.4.4.1. Market size, by technology, 2019-2026 6.4.4.2. Market size, by applications, 2019-2026 6.4.5. China 6.4.5.1. Market size, by technology, 2019-2026 6.4.5.2. Market size, by applications, 2019-2026 6.4.6. Japan 6.4.6.1. Market size, by technology, 2019-2026 6.4.6.2. Market size, by applications, 2019-2026 6.4.7. Australia 6.4.7.1. Market size, by technology, 2019-2026 6.4.7.2. Market size, by applications, 2019-2026 6.5. Latin America 6.5.1. Market size, by country, 2019-2026 6.5.2. Market size, by technology, 2019-2026 6.5.3. Market size, by applications, 2019-2026 6.5.4. Argentina 6.5.4.1. Market size, by technology, 2019-2026 6.5.4.2. Market size, by applications, 2019-2026 6.5.5. Brazil 6.5.5.1. Market size, by technology, 2019-2026 6.5.5.2. Market size, by applications, 2019-2026 6.5.6. Mexico 6.5.6.1. Market size, by technology, 2019-2026 6.5.6.2. Market size, by applications, 2019-2026 6.6. Middle East and Africa 6.6.1. Market size, by country, 2019-2026 6.6.2. Market size, by technology, 2019-2026 6.6.3. Market size, by applications, 2019-2026 6.6.4. South Africa 6.6.4.1. Market size, by technology, 2019-2026 6.6.4.2. Market size, by applications, 2019-2026 6.6.5. Saudi Arabia 6.6.5.1. Market size, by technology, 2019-2026 6.6.5.2. Market size, by applications, 2019-2026 Chapter 7 Consolidations 7.1. Mergers and Acquisitions 7.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 7.3. Patent Analysis 7.4. Key players 7.4.1. Gilead 7.4.1.1. Company overview 7.4.1.2. Key financials 7.4.1.3. Product landscape 7.4.1.4. Strategic initiatives 7.4.1.5. SWOT analysis 7.4.2. Celgene 7.4.2.1. Company overview 7.4.2.2. Key financials 7.4.2.3. Product landscape 7.4.2.4. Strategic initiatives 7.4.2.5. SWOT analysis 7.4.3. Abbott 7.4.3.1. Company overview 7.4.3.2. Key financials 7.4.3.3. Product landscape 7.4.3.4. Strategic initiatives 7.4.3.5. SWOT analysis 7.4.4. Novo Nordisk A/S 7.4.4.1. Company overview 7.4.4.2. Key financials 7.4.4.3. Product landscape 7.4.4.4. Strategic initiatives 7.4.4.5. SWOT analysis 7.4.5. Novartis AG 7.4.5.1. Company overview 7.4.5.2. Key financials 7.4.5.3. Product landscape 7.4.5.4. Strategic initiatives 7.4.5.5. SWOT analysis 7.4.6. Sanofi Aventis 7.4.6.1. Company overview 7.4.6.2. Key financials 7.4.6.3. Product landscape 7.4.6.4. Strategic initiatives 7.4.6.5. SWOT analysis 7.4.7. Lonza 7.4.7.1. Company overview 7.4.7.2. Key financials 7.4.7.3. Product landscape 7.4.7.4. Strategic initiatives 7.4.7.5. SWOT analysis 7.4.8. Johnson & Johnson Services, Inc. 7.4.8.1. Company overview 7.4.8.2. Key financials 7.4.8.3. Product landscape 7.4.8.4. Strategic initiatives 7.4.8.5. SWOT analysis 7.4.9. F. Hoffmann-La Roche Ltd 7.4.9.1. Company overview 7.4.9.2. Key financials 7.4.9.3. Product landscape 7.4.9.4. Strategic initiatives 7.4.9.5. SWOT analysis 7.4.10. Pfizer 7.4.10.1. Company overview 7.4.10.2. Key financials 7.4.10.3. Product landscape 7.4.10.4. Strategic initiatives 7.4.10.5. SWOT analysis 7.4.11. Merck & Co. 7.4.11.1. Company overview 7.4.11.2. Key financials 7.4.11.3. Product landscape 7.4.11.4. Strategic initiatives 7.4.11.5. SWOT analysis 7.4.12. Biogen 7.4.12.1. Company overview 7.4.12.2. Key financials 7.4.12.3. Product landscape 7.4.12.4. Strategic initiatives 7.4.12.5. SWOT analysis 7.4.13. AstraZeneca 7.4.13.1. Company overview 7.4.13.2. Key financials 7.4.13.3. Product landscape 7.4.13.4. Strategic initiatives 7.4.13.5. SWOT analysis 7.4.14. Amgen, Inc. 7.4.14.1. Company overview 7.4.14.2. Key financials 7.4.14.3. Product landscape 7.4.14.4. Strategic initiatives 7.4.14.5. SWOT analysis 7.4.15. Genentech 7.4.15.1. Company overview 7.4.15.2. Key financials 7.4.15.3. Product landscape 7.4.15.4. Strategic initiatives 7.4.15.5. SWOT analysis 7.4.16. Cosmos Holdings Inc. 7.4.16.1. Company overview 7.4.16.2. Key financials 7.4.16.3. Product landscape 7.4.16.4. Strategic initiatives 7.4.16.5. SWOT analysis 7.4.17. Adamis Pharmaceuticals Corporation 7.4.17.1. Company overview 7.4.17.2. Key financials 7.4.17.3. Product landscape 7.4.17.4. Strategic initiatives 7.4.17.5. SWOT analysis 7.4.18. CASI Pharmaceuticals, Inc. 7.4.18.1. Company overview 7.4.18.2. Key financials 7.4.18.3. Product landscape 7.4.18.4. Strategic initiatives 7.4.18.5. SWOT analysis 7.4.19. Protalix BioTherapeutics, Inc. 7.4.19.1. Company overview 7.4.19.2. Key financials 7.4.19.3. Product landscape 7.4.19.4. Strategic initiatives 7.4.19.5. SWOT analysis 7.4.20. Infinity Pharmaceuticals, Inc. 7.4.20.1. Company overview 7.4.20.2. Key financials 7.4.20.3. Product landscape 7.4.20.4. Strategic initiatives 7.4.20.5. SWOT analysis 7.4.21. GSK 7.4.21.1. Company overview 7.4.21.2. Key financials 7.4.21.3. Product landscape 7.4.21.4. Strategic initiatives 7.4.21.5. SWOT analysis 7.4.22. Genentech 7.4.22.1. Company overview 7.4.22.2. Key financials 7.4.22.3. Product landscape 7.4.22.4. Strategic initiatives 7.4.22.5. SWOT analysis 7.4.23. Genzyme 7.4.23.1. Company overview 7.4.23.2. Key financials 7.4.23.3. Product landscape 7.4.23.4. Strategic initiatives 7.4.23.5. SWOT analysis 7.4.24. IntegraGen 7.4.24.1. Company overview 7.4.24.2. Key financials 7.4.24.3. Product landscape 7.4.24.4. Strategic initiatives 7.4.24.5. SWOT analysis 7.4.25. LabCorp Diagnostic 7.4.25.1. Company overview 7.4.25.2. Key financials 7.4.25.3. Product landscape 7.4.25.4. Strategic initiatives 7.4.25.5. SWOT analysis

About This Report

Report ID10844
Category Healthcare
Published Dateoct 2019
No of Pages175
Contact Us